Creative Biolabs-Immuno-oncology

Anti-EGP2 (clone 32E3/A3) SynExpress E1-R-β-N Modified CD8+ T cells (CAT#: ITS-1224-CR2626)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target EGP2 (clone 32E3/A3). We employs the Adenovirus (EF1α-RFP-β-catenin-NotI) vector components and the SynExpress system of the DNA methylation sites Knock-in/Positive feedback for a robust and sustained response against cancers.
Host
Rabbit
Target
EGP2
Clone
32E3/A3
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
RFP
Promoter
EF1α
Effector Gene
β-catenin
Insertion Sites
NotI
Gene Modification
Knock-in
Modification Domain
DNA methylation sites
Carrier Type
Adenovirus
Transformation Accuracy
0.95
Cell Culture
Aseptic Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.